UI Hospitals and Clinics
A randomized double-blind, placebo-controlled study of LEE011 in combination with letrozole for the treatment of postmenopausal women with hormone receptor positive, HER2-negative, advanced breast cancer who received no prior therapy for advanced disease
Participants in this study have been diagnosed with breast cancer. Studies have shown that blocking a certain pathway has the potential to control ER+ breast cancer progression. The purpose of this study is to test the efficacy of using LEE011 in combination with letrozole to prolong progression free survival in postmenopausal women with advanced breast cancer. About 500 participants will take part in this study at multiple sites; approximately 16 participants will take part in this study at the University of Iowa.
Michelle Arnold 319-356-2778
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.